Marcus Mall
Researcher Next ID · RN-032318
Researcher · Health Professions
Association for Symbolic Logic
Storrs, Germany
- Works count
- 1,222
- Citation count
- 27,877
- H-index
- 83
- i10-index
- 301
Research interests
Publications
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells
Nature · 2021 · https://doi.org/10.1038/s41586-021-04142-6
SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself
Nature Communications · 2021 · https://doi.org/10.1038/s41467-021-22210-3
Cross-reactive CD4 + T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
Science · 2021 · https://doi.org/10.1126/science.abh1823
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children
Nature Biotechnology · 2021 · https://doi.org/10.1038/s41587-021-01037-9
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Nature · 2020 · https://doi.org/10.1038/s41586-020-2598-9
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1908639
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)32597-8
VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1807120
Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice
Nature Medicine · 2004 · https://doi.org/10.1038/nm1028
Current projects
No projects listed.